United Guardian INC 10-Q quarterly reports

United-Guardian, Inc. announced a 10% increase in net sales for Q2 2026 and a 12% increase for the first half, driven by pharmaceutical and cosmetic ingredient sales, alongside improved net income.

United-Guardian reports a 16% increase in Q1 2026 net sales, driven by strong performance in pharmaceutical products and cosmetic ingredients, alongside a significant settlement income.

United-Guardian, Inc. reported a significant decline in net sales and net income for Q3 2025, primarily driven by a sharp drop in cosmetic ingredient sales to China.

United-Guardian, Inc. reported a significant decline in net sales and net income for the second quarter and first half of 2025, primarily driven by reduced demand for cosmetic ingredients in China due to tariffs and trade uncertainty.

United-Guardian's Q1 2025 net sales decreased by 24% year-over-year, primarily due to lower cosmetic ingredient sales, despite growth in pharmaceutical and medical lubricant segments.

United-Guardian Inc. saw a slight increase in net sales for the third quarter of 2024, with significant growth in cosmetic ingredient sales offsetting declines in pharmaceutical sales.

United-Guardian, Inc. saw a significant increase in net sales and profitability in the second quarter and first half of 2024, primarily driven by strong demand for its cosmetic ingredients.

United-Guardian Inc. saw a significant increase in net sales for the first quarter of 2024, primarily driven by a surge in cosmetic ingredient sales.